SEAT Form 4: CFO Fey Converts 5,229 RSUs to Class A Shares on 09/11/2025
Rhea-AI Filing Summary
Lawrence Fey, CFO of Vivid Seats Inc. (SEAT), reported acquisitions of restricted stock units and increases in beneficial ownership. The Form 4 shows two grant events on 09/11/2025: 1,192 RSUs and 4,037 RSUs were reported as acquired, each representing a contingent right to one share of Class A common stock. After these transactions, Mr. Fey beneficially owned 60,492 and 64,529 shares in the two reported lines, and holds derivative RSUs covering 1,192 and 4,037 underlying Class A shares. Vesting schedules are disclosed: one-third of each award vested earlier (one tranche on 03/11/2024 and one on 03/11/2025) with the remainder vesting in equal quarterly installments through March 11, 2026 and March 11, 2027 respectively. The RSUs have no expiration dates.
Positive
- Transparent disclosure of RSU vesting schedules and underlying share counts provides clarity for investors and regulators
- RSUs have no expiration, ensuring the executive retains the right to underlying shares as they vest
Negative
- None.
Insights
TL;DR: Insider increased holdings through RSU vesting events, reflecting scheduled compensation rather than open-market purchases.
The filing documents scheduled vesting of previously granted restricted stock units for the CFO, resulting in modest increases in beneficial ownership. The transactions are coded as 'M', indicating ordinary vesting or conversion of derivative securities into underlying Class A shares. The disclosed vesting schedules and absence of price paid (zero exercise price for RSUs) suggest these are compensation-related grants converting to shares as they vest rather than discretionary acquisitions. For investors, this is a routine insider compensation activity and not an indication of market-timed buying or selling.
TL;DR: The disclosure is standard and transparent, providing clear vesting timelines and share counts for governance oversight.
The Form 4 provides the necessary particulars: dates, amounts, ownership form, and explanatory notes describing vesting cadence and lack of expiration. This level of detail supports internal controls and public transparency around executive compensation. There is no indication of irregular transfers, pledging, or disposal of shares. The filing is timely and signed, meeting statutory disclosure expectations under Section 16.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 1,192 | $0.00 | -- |
| Exercise | Restricted Stock Units | 4,037 | $0.00 | -- |
| Exercise | Class A Common Stock | 1,192 | $0.00 | -- |
| Exercise | Class A Common Stock | 4,037 | $0.00 | -- |
Footnotes (1)
- Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A common stock. One-third of the RSUs vested on March 11, 2024. The remainder of the RSUs vest in equal quarterly installments such that they will be fully vested on March 11, 2026. The RSUs do not have an expiration date. One-third of the RSUs vested on March 11, 2025. The remainder of the RSUs vest in equal quarterly installments such that they will be fully vested on March 11, 2027. The RSUs do not have an expiration date.
